Better than nothing: keeping pts on failing regimen has benefits.
In a retrospective study of HIV-infected patients, those with CD4+ lymphocyte count 50-200, and < 50 who had detectable HIV RNA levels on combination antiretroviral therapy (cART), a 34% and 22% reduction, respectively, in new AIDS-defining events (ADE) was observed in patients who continued cART compared to patients who stopped cART.
Winslow
Dean L
DL
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D019562:Viral Load
D019380:Anti-HIV Agents; D012367:RNA, Viral